Swiss National Bank’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
HA
CII
Swiss National Bank's ONC Position: Q4 2022 in Review
Swiss National Bank sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 128,785 shares — an estimated $17.4M sold.
Swiss National Bank first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $45.5M in Q3 2020. 213 funds tracked by Wall St. Rank hold ONC as of Q4 2022.
- Swiss National Bank reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
- Swiss National Bank sold 128,785 BeOne Medicines Ltd shares in Q4 2022, an estimated $17.4M.
- Swiss National Bank first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
- Swiss National Bank's BeOne Medicines Ltd position peaked at $45.5M in Q3 2020.
- 213 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.
Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.